Medial Research Network

COVID-19

Stay up-to-date with the latest news and information from MRN about our involvement in helping fight COVID 19

FAQs

Due to the number of questions and RFPs we are receiving, we have produced a series of FAQs to help you get to the information you want, quickly. Below, you'll find a variety of FAQs covering country coverage, ESU, HTS and supplies. Please continue to regularly check back with us as we'll be updating these as we receive more questions.

- Country Coverage FAQs

- Expedited Start-Up (ESU) FAQs

- General FAQs

- HTS Staff FAQs

- Supplies FAQs

International Responses to COVID 19

As a service to you, our colleagues, we've built a presentation comprised of the International Responses to COVID 19 from Europe, UK, North America and Australasia. It also covers guidance for GCP & Clinical Trials and PPE. We hope you find this helpful during these challenging times. This resource is updated every Tuesday so be sure to check back weekly for new information.

MRN Pandemic Response

An update from our CEO, Dr Graham Wylie

"We are the leading exponents of Home-based Clinical Trials.  We have the systems, processes, people and expertise.  To respond to the pandemic, we are accelerating our already rapid growth with even greater levels of recruitment and training."

Selecting the Right Support Systems for Home-Based Clinical Trials

As the leading experts in Home-based Clinical Trials, MRN are working closely with the companies leading the development of this exciting telemedicine field. To learn more about how MRNs Home Trial Support Services can help you successfully navigate through the labyrinth of moving your clinical trials further into the community please contact us using the button below or at HTSinfo@themrn.co.uk

MRN ON TWITTER